Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Stem Cell & Regenerative Therapy Markets to 2024 Featuring Aldagen, Caladrius Biosciences, Daiichi Sankyo Co, Gamida Cell, Novartis, and More


DUBLIN, Aug. 20, 2019 /PRNewswire/ -- The "Global Stem Cell and Regenerative Therapy Market: A Research Outlook" report has been added to ResearchAndMarkets.com's offering.

The Report Includes:

Research and Markets Logo

Growth of the global market is attributed to the factors such as the growing prevalence of cancer, technological advancement in the product, growing adoption of novel therapeutics such as cell therapy, gene therapy in the treatment of chronic diseases and increasing investment from private players in cell-based therapies.

In the global market, North America held the highest market share in 2018. The Asia-Pacific region is anticipated to grow at the highest CAGR during the forecast period. The growing government funding for regenerative medicines in research institutes along with the growing number of clinical trials based on cell-based therapy and investment in R&D activities is expected to supplement the growth of the stem cell and regenerative market in Asia-Pacific region during the forecast period.

Scope

The scope of this report is broad and covers various type of product available in the stem cell and regenerative medicines market and potential application sectors across various industries. The current report offers a detailed analysis of the stem cell and regenerative medicines market.

The report highlights the current and future market potential of stem cell and regenerative medicines and provides a detailed analysis of the competitive environment, recent development, merger and acquisition, drivers, restraints, and technology background in the market. The report also covers market projections through 2024.

The report details market shares of stem cell and regenerative medicines based on products, application, and geography. Based on product the market is segmented into therapeutic products, cell banking, tools and reagents. The therapeutics products segments include cell therapy, tissue engineering and gene therapy. By application, the market is segmented into oncology, cardiovascular disorders, dermatology, orthopedic applications, central nervous system disorders, diabetes, others

The market is segmented by geography into the following regions: North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. The report presents detailed analyses of major countries such as the U.S., Canada, Mexico, Germany, the U.K. France, Japan, China and India. For market estimates, data is provided for 2018 as the base year, with forecasts for 2019 through 2024. Estimated values are based on product manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Reasons for Doing This Study

Global stem cell and regenerative medicines market comprises of various products for novel therapeutics that are adopted across various applications. New advancement and product launches have influenced the stem cell and regenerative medicines market and it is expected to grow in the near future.

The biopharmaceutical companies are investing significantly in cell-based therapeutics. Government organizations are funding research and development activities related to stem cell research. These factors are impacting the stem cell and regenerative medicines market positively and augmenting the demand for stem cell and regenerative therapy among different application segments.

The market is impacted by the adoption of stem cell therapy. The key players in the market are investing in the development of innovative products. The stem cell therapy market is likely to grow during the forecast period owing to growing investment from private companies, increasing in regulatory approval of stem cell-based therapeutics for the treatment of chronic diseases and growth in commercial applications of regenerative medicine.

Products based on stem cells do not yet form an established market, but unlike some other potential applications of bioscience, stem cell technology has already produced many significant products in important therapeutic areas. The potential scope of the stem cell market is now becoming clear, and it is appropriate to review the technology, see its current practical applications, evaluate the participating companies and look to its future.

Key Topics Covered

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Chapter 4 Market Dynamics

Chapter 5 Market Breakdown by Product

Chapter 6 Market Breakdown by Application

Chapter 7 Market Breakdown by Region

Chapter 8 Regulatory Scenario

Chapter 9 Patent Analysis

Chapter 10 Competitive Landscape

Chapter 11 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/3ojt53

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 08:10
Edgewise Receives European Medicines Agency (EMA) Orphan Drug Designations for Sevasemten (EDG-5506) for the Treatment of Becker and Duchenne Muscular Dystrophies
Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designations for sevasemten for the treatment of Becker muscular dystrophy (Becker)...

at 08:10
Tentarix Biotherapeutics Announces the Appointment of Andrew D. Kidd, MD, CFA, as CEO
Tentarix Biotherapeutics today announced the appointment of Andrew Kidd, MD, as chief executive officer. Mr. Kidd joins Tentarix with a distinguished career of over two decades of executive and biotech experience. He was most recently the president...

at 08:09
Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024
Perrigo Company plc , a leading provider of Consumer Self-Care Products, today announced that it plans to issue its first quarter 2024 financial results on Tuesday, May 7th, 2024, and host a conference call beginning at 8:30 A.M. (EDT)....

at 08:07
Demystifying Acupuncture: Modern Answers About Ancient Medicine Offers an Insightful Guide to Understanding the Healing Powers of Acupuncture
While many individuals are familiar with acupuncture and may have experienced it firsthand, few possess a deep comprehension of its underlying mechanisms or how it diverges from conventional medical practices in its approach.  Acupuncturist, medical...

at 08:05
CG Life Specialty Agency The Market Element Relaunches as Element CG
CG Life specialty marketing communications agency Element CG, formerly The Market Element, today announced a brand relaunch to align more closely with its focus on supporting emerging life sciences and biopharma companies with scientific marketing...

at 08:05
Rubedo Life Sciences and Beiersdorf Announce Multi-Year Partnership to Pioneer New Skin Care Products that Address Cellular Aging
Rubedo Life Sciences, a biotechnology company specializing in cellular senescence and anti-aging research, announced today a multi-year strategic partnership with German multinational beauty company Beiersdorf AG to develop innovative skin care...

More news about Health...


News published on and distributed by: